News Focus
News Focus
icon url

growingpain

08/18/22 5:33 AM

#370873 RE: Investor2014 #370872

"Will there be another opportunity to take substantial $AVXL profit and live with the potential that an even bigger, not return percentage, but absolute return could have been had?"

I believe even if someone got in at $10+, the AD trial fails and we go back to low single-digits, there may be an opportunity to break even with Rett. But if Rett fails, it will be the greatest lesson in my 15-year biotech-investing experience.
icon url

LakeshoreLeo1953

08/18/22 8:17 AM

#370877 RE: Investor2014 #370872

Better late than never.
Many here with the scars of disapproval for ALREADY pursuing such a course.
icon url

kevindenver

08/18/22 8:47 AM

#370883 RE: Investor2014 #370872

$AVXL is a We Got This (WGT) stock until the science fails a trial.

$AVXL is becoming a classic binary event biotech play, and the sane back up plan for most investors should be to brace for 100% loss of the investment. Thus the $AVXL allocation should be based on individualized client parameters and suitability.
^^^^ that's my compliance approved version for financial advisor types.

But...my no longer registered advice is follow the trail of evidence regarding the growing confirmatory emerging science of S1R and muscarinic modulation and bet for success.

"Gotta be in it to win it", "Once in a lifetime opportunity" and other cliches apply to those comfortable with the risks.